The present invention provides PLK1 inhibitor compounds of formula I: Useful in the treatment or control of cell proliferative disorders, particularly oncological disorders. These compounds and formulations containing such compounds may be useful in the t
-
Page/Page column 23
(2008/12/08)
More Articles about upstream products of 1062244-39-6